- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05278455
Self-help Lifestyle Medicine for Generalized Anxiety Symptoms
Smartphone-Delivered Lifestyle Medicine Intervention for Generalized Anxiety Symptoms: A Randomized Controlled Trial
This study will examine the effects of smartphone-based lifestyle medicine for alleviating generalised anxiety symptoms in Chinese population. Since a range of lifestyle factors are involved in the pathogenesis and progression of generalised anxiety disorder ( Cox & Olatunji, 2016; Dale et al., 2014; Vøllestad et al., 2012), modifying different lifestyle factors simultaneously, for examples, diet, exercise, stress and sleep, may be effective to reduce generalised anxiety symptoms. Recent studies indicate that service users are showing an increasing interest in self-help interventions for common mental disorders because of their accessibility and low cost (Marshall et al., 2021; Weisel et al., 2019). Nonetheless, to date, only limited self-help interventions that target lifestyle medicine for generalised anxiety symptoms are available.
This study will be a randomised controlled trial on the effects of a self-help smartphone-based lifestyle medicine intervention for reducing generalised anxiety symptoms in Chinese population. Prior to all study procedures, eligible participants will be required to complete an online informed consent (with telephone support). Around 50 eligible participants will be randomly assigned to either smartphone-based lifestyle medicine (LM group) or the waitlist control group (WL group) in a ratio of 1:1. The randomization will be performed by an independent assessor using a computer-generated list of numbers. Participants in the LM group will receive the multicomponent lifestyle medicine intervention via the app for 8 weeks, whilst the WL control group will receive the intervention after trial completion. The primary outcomes will be the level of generalised anxiety symptoms at immediate and 3-month post-intervention assessments; while the secondary outcomes will be the level of depressive symptoms, insomnia symptoms, physical activity, health-related quality of life, functional impairment, health-promoting behaviours, and intervention acceptability at immediate and 3-month post-intervention assessments.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Vincent Wing-Hei Wong, PhD student in Psychology
- Phone Number: +852 39436575
- Email: vincentwongWH@link.cuhk.edu.hk
Study Locations
-
-
-
Sha Tin, Hong Kong
- The Chinese University of Hong Kong
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Hong Kong residents
- Aged ≥ 18 years
- Have a Generalized Anxiety Disorder-7 (GAD-7) score ≥ 8
- Able to read Chinese and type in Chinese or English
- Have an Internet-enabled mobile device (iOS or Android operating system)
- Willing to provide informed consent and comply with the trial protocol
Exclusion Criteria:
- Current involvement in psychotherapy or recent changes in medication for anxiety
- A Patient Health Questionnaire-9 (PHQ-9) item 9 score > 2, indicating a serious level of suicidal risk (referral information to professional mental health services will be provided)
- Self-disclosure of having unsafe health conditions for which physical activity or a change in diet was contraindicated by physicians
- Self-disclosure of a diagnosis of any major psychiatric, medical or neurocognitive disorders that make participation unsuitable or that may interfere with the adherence to the lifestyle modifications
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Lifestyle Medicine Group
Lifestyle medicine smartphone app The lifestyle medicine app contains eight weekly modules that cover healthy eating, exercise, stress management, sleep management, lifestyle psychoeducation, and goal setting.
|
A smartphone-delivered application with a series of lifestyle medicine components, including lifestyle psychoeducational, physical activity, dietary recommendations, stress management, sleep management, and motivation and goal-setting techniques.
|
No Intervention: Waitlist Control Group
The waitlist control group will receive access to the lifestyle medicine app at the end of the study.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in the Generalized Anxiety Disorder-7 (GAD-7)
Time Frame: Baseline, immediate post-intervention, and 3-month post-intervention
|
GAD-7 is a seven-item scale for assessing the level of generalized anxiety in the past two weeks.
It comprises questions related to feelings of anxious and worry in daily lives.
This four-point Likert scale is rated from 0 (not at all) to 3 (almost everyday), and the cut off score on the sum of each item will be the standard to differentiate the anxiety level (5, 10, 15 correspond to mild, moderate and severe respectively)
|
Baseline, immediate post-intervention, and 3-month post-intervention
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in the Patient Health Questionnaire (PHQ-9)
Time Frame: Baseline, immediate post-intervention, and 3-month post-intervention
|
PHQ-9 is a nine-item scale for assessing the level of depressive symptoms in the past two weeks.
This four-point Likert scale is rated from 0 (not at all) to 3 (almost every day), and the cut off scores on the sum of each item will be the standard to differentiate the depressive level (5, 10, 15, 20 correspond to mild, moderate, moderately severe and severe respectively)
|
Baseline, immediate post-intervention, and 3-month post-intervention
|
Change in the Insomnia Severity Index (ISI)
Time Frame: Baseline, immediate post-intervention, and 3-month post-intervention
|
ISI is a seven-item scale for measuring the severity of sleep disturbance.
This five-point Likert scale is rated from 0 to 4 for each item, and a higher total score indicates the more severe of the insomnia condition (8, 15, 22 correspond to subthreshold insomnia, moderate clinical insomnia and severe clinical insomnia respectively).
|
Baseline, immediate post-intervention, and 3-month post-intervention
|
Change in the Short Form (Six-Dimension) Health Survey (SF-6D)
Time Frame: Baseline, immediate post-intervention, and 3-month post-intervention
|
SF-6D is a single index and preference-based questionnaire for measuring individual's quality of lives in the following six domains, including physical functioning, role limitation, social functioning, bodily pain, mental health, and vitality.
|
Baseline, immediate post-intervention, and 3-month post-intervention
|
Change in the Health-Promoting Lifestyle Profile (HPLP II)
Time Frame: Baseline, immediate post-intervention, and 3-month post-intervention
|
HPLP-II is a 52-item questionnaire for measuring the present lifestyle or personal habits with six sub-scale domains, including health responsibility, physical activity, nutrition, spiritual growth, interpersonal relations, and stress management.
The inventory uses a four-point Likert scale, from 1 (never) to 4 (routinely), to evaluate the frequency of items asked to the participants.
|
Baseline, immediate post-intervention, and 3-month post-intervention
|
Change in the Sheehan Disability Scale (SDS)
Time Frame: Baseline, immediate post-intervention, and 3-month post-intervention
|
SDS is a three-item, self-reported 10-point visual analog scale on measuring one's severity level of impairment on three dimensions, including work/school, social life, and family life.
|
Baseline, immediate post-intervention, and 3-month post-intervention
|
Change in the Credibility-Expectancy Questionnaire (CEQ)
Time Frame: Baseline and immediate post-intervention
|
CEQ is a self-reported 6-item inventory for assessing one's attitude towards the credibility and expectancy of the intervention contents.
|
Baseline and immediate post-intervention
|
Change in the Treatment Acceptance Questionnaire (TAQ)
Time Frame: Baseline and immediate post-intervention
|
TAQ is a self-reported, six-item questionnaire that is rated by a seven-point Likert scale from 1 to 7, and it aims at evaluating the clients' attitude toward the treatment sessions by six domains, including acceptability, ethics, effectiveness, negative side effects, the therapist's knowledge, and the therapist's trustworthiness.
|
Baseline and immediate post-intervention
|
Change in the International Physical Activities Questionnaire-Chinese version (IPAQ-C)
Time Frame: Baseline, immediate post-intervention, and 3-month post-intervention
|
IPAQ-C is a 5-item questionnaire that measures the amount of sitting time, walking time, and moderate and vigorous exercise during the last 7 days.
Different exercise types are categorized and rated as different metabolic equivalent tasks, while a higher score of the sum of total items represents a higher intense of activity level.
|
Baseline, immediate post-intervention, and 3-month post-intervention
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Anticipated)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- PSY020
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Generalised Anxiety Disorder
-
National Healthcare Group, SingaporeSingapore General Hospital; Nanyang Technological University; Duke-NUS Graduate...Recruiting
-
University College, LondonNational Institute for Health Research, United Kingdom; NHS Health Technology...TerminatedGeneralised Anxiety DisorderUnited Kingdom
-
UCLH/UCL Joint Research OfficeMedical Research Council; Camden and Islington NHS Trust; Central and North West...RecruitingAnxiety Disorders | Anxiety | Anxiety Depression | CBT | Anxiety Disorders and Symptoms | Anxiety Generalized | Generalised Anxiety Disorder | Anxiety Disorder; Mixed With Depression (Mild) | Anxiety Disorder GeneralizedUnited Kingdom
-
Norfolk and Suffolk NHS Foundation TrustUniversity of East AngliaCompletedMental Health Issue (E.G., Depression, Psychosis, Personality Disorder, Substance Abuse) | Schizophrenia | Bipolar Disorder | Generalised Anxiety DisorderUnited Kingdom
-
University of California, San DiegoRecruitingPulse Oximetry | Generalised Melanin PigmentationUnited States
-
Yale UniversityNational Institute of Mental Health (NIMH)Active, not recruitingGeneralized Anxiety Disorder | Anxiety Disorder of Childhood | Separation Anxiety Disorder of Childhood | Social Anxiety Disorder of ChildhoodUnited States
-
Szeged UniversityCompletedCoping Skills | Mood | COVID-19 Pandemic | Psychological Stress | Subjective Health Complaint | Questionnaire Designs | Two-Item Generalised Anxiety Disorder Scale | Patient Health Questionnaire Anxiety and Depression Scale | Health Status IndexHungary
-
University of MichiganBrain & Behavior Research FoundationRecruitingGeneralized Anxiety Disorder | Anxiety | Social Anxiety Disorder | Panic DisorderUnited States
-
Baylor College of MedicineUniversity of PennsylvaniaRecruitingGeneralized Anxiety Disorder | Anxiety | Autism Spectrum Disorder | Separation Anxiety | Social Anxiety Disorder of ChildhoodUnited States
-
Erasmus Medical CenterTerminatedGeneralized Anxiety Disorder | Social Anxiety Disorder | Specific Phobia | Anxiety Disorder | Anxiety Disorder of Childhood | Separation Anxiety Disorder of Childhood, Early OnsetNetherlands
Clinical Trials on Lifestyle Medicine
-
Chinese University of Hong KongUniversity of Melbourne; University of Western SydneyUnknown
-
Chinese University of Hong KongThe University of Hong Kong; The Hong Kong Polytechnic University; University... and other collaboratorsUnknown
-
Chinese University of Hong KongNot yet recruiting
-
Northern Ontario School of MedicineRecruitingHeart Diseases | Hypertension | Obesity | Diabetes | High CholesterolCanada
-
Chinese University of Hong KongNot yet recruiting
-
Chinese University of Hong KongUnknown
-
Chinese University of Hong KongUnknown
-
Scripps Center for Integrative MedicineUnknown
-
Ohio UniversityCompletedCardiovascular Diseases | Hypertension | Diabetes | Dyslipidemias | Overweight and Obesity | Chronic Lifestyle Related DiseaseUnited States
-
Chinese University of Hong KongUniversity of Melbourne; University of Western SydneyCompletedPsychological WellbeingHong Kong